Chinese CROs to Adopt OmniComm TrialOne Solution

Article

OmniComm Systems announces the signing of contracts to provide the company’s TrialOne clinical automation solution to three clinical research organizations in China.

OmniComm Systems announces the signing of contracts to provide the company’s TrialOne clinical automation solution to three clinical research organizations in China. The agreements for TrialOne were made with Xiyuan Hospital, the Chinese Anti-Cancer Association (CACA) and eStart Medical Technology Co., Ltd.

Read the full release here

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.